Two separate meetings are planned. The largest, "Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Treatment," will be held at the Westin Los Angeles Airport Hotel, 5400 West Century Boulevard, Los Angeles, on November 1 and 2.

The focus of this meeting is to catalyze partnerships to facilitate moving drug addiction research into clinical practice. Over the past few years, this research has yielded fresh insights into the effects of drugs on the structure and function of the brain. This enhanced understanding has opened doors to new approaches to treatment and prevention of drug abuse and addiction.

Local officials, drug treatment counselors, social workers, criminal justice staff, marriage and family counselors, and public health workers who treat individuals with drug abuse or addiction problems are expected to attend. Civic leaders and policymakers who wish to learn more about drug addiction and treatment are also expected to attend.

Discussion topics include:

• Putting Drug Abuse Research to Use in Real-Life Settings;

• The Burden of Disease in Los Angeles;

• Los Angeles County Evaluation System/LACES;

• Forging Partnerships To Enhance Drug Treatment: Focus on Los Angeles; and

• Forging Partnerships: Next Steps for Los Angeles.

Workshops will be held on the effects of drugs on the brain and behavior; club drugs; gender issues in treatment; methamphetamine treatment; the effectiveness of treatment; innovations in medication development for treating addiction; gender issues in drug abuse treatment; and other subjects.

In addition to NIDA Director Dr. Alan I. Leshner, featured speakers include Jonathan Fielding, Director of Public Health in Los Angeles County; Dr. Peter C. Whybrow, Chair of the Department of Psychiatry and Behavioral Sciences, UCLA; and other California-based health officials and researchers.

Prior to the "Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Treatment" meeting, NIDA is convening its National Drug Abuse Treatment Clinical Trials Network (CTN) investigators to discuss research and treatment advances that have evolved out of this program. This network is modeled on clinical trial designs that have been successful in contributing to the development and testing of treatment regimens for diseases such as cancer, stroke, and heart disease. It is the first time the clinical trial network model has been applied to addiction treatment. It allows researchers and treatment providers, working in partnership, to test, in real-life settings, science-based behavioral and pharmacological treatments for addiction. The University of California at Los Angeles is a member of the Clinical Trials Network.

Note to reporters: The CTN meeting is October 30 to 31. Media are invited to attend the October 31 session, which begins at 8:30 a.m., to learn about progress in drug addiction treatment. The CTN meeting is at the Westin Los Angeles Airport Hotel. For more information and to register, call the NIDA Press Office, 301-443-6245.

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and other topics can be ordered free of charge in English and Spanish through NIDA Infofax at 1-888-NIH-NIDA (644-6432) or 1-888-TTY-NIDA (889-6432) for the deaf. These fact sheets and further information on NIDA research and other activities can be found on the NIDA home page at http://www.drugabuse.gov.